Genzyme Corporation Chief Could Reap $221.2M in Sanofi-Aventis (France) Deal

Xconomy -- Genzyme chief executive Henri Termeer is due to take in $158.4 million from French drug giant Sanofi-Aventis’s buyout of his Cambridge, MA-based biotech firm, Bloomberg reported.

MORE ON THIS TOPIC